Cowealth Medical China Co.,Ltd. (SHA:603122)
China · Delayed Price · Currency is CNY 17.78
-0.02 (-0.11%)
Jan 30, 2026, 4:00 PM EST
Cowealth Medical China Revenue
Cowealth Medical China had revenue of 181.20M CNY in the quarter ending September 30, 2025, a decrease of -21.27%. This brings the company's revenue in the last twelve months to 777.03M, down -19.93% year-over-year. In the year 2024, Cowealth Medical China had annual revenue of 939.14M, down -14.05%.
Revenue (ttm)
777.03M
Revenue Growth
-19.93%
P/S Ratio
9.41
Revenue / Employee
3.83M
Employees
203
Market Cap
7.31B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 939.14M | -153.46M | -14.05% |
| Dec 31, 2023 | 1.09B | -187.06M | -14.62% |
| Dec 31, 2022 | 1.28B | 88.61M | 7.44% |
| Dec 31, 2021 | 1.19B | 102.04M | 9.37% |
| Dec 31, 2020 | 1.09B | 42.05M | 4.02% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dian Diagnostics Group | 10.50B |
| Shanghai Runda Medical Technology | 7.40B |
| Maccura Biotechnology Co.Ltd | 2.21B |
| Shanghai Labway Clinical Laboratory | 1.52B |
| Medicalsystem Biotechnology | 1.47B |
| Beijing Strong Biotechnologies,Inc. | 1.43B |
| Thalys Medical Technology Group | 1.25B |
| Amoy Diagnostics | 1.13B |